Aussprung L. Fraud and abuse: federal civil medical care litigation and
settlement. J Leg Med. 1998;19:1–62.
Bennett T, Gerber RS, Mueller DG Jr. Making sense of antitrust policy: its
application to physician directed networks.
Mo Med. 1997;94:180–184.
Bloche MG. Cutting waste and keeping faith.
Ann Intern Med. 1998;128:688–689.
Boyd W III. Combating fraud and abuse: anti-kickback statute.
Iowa Med. 1997;87:23–24.
Boyer MM. Fraud and abuse gaining attention amid national E&M guideline
controversy. Pa Med. 1998;101:12.
Cook DA. Fraud, abuse, and beyond: costly pitfalls for physicians who serve
Medicare and Medicaid patients. J Med Assoc Ga. 1997;86:321–324.
Cook DA. New antitrust rules ease restrictions on physician networks.
Assoc Ga. 1996;85:257–259.
DeWitt AL. The citizen attorney general and Medicare fraud.
Mo Med. 1996;93:688–689.
Dranove D, White WD. Emerging issues in the antitrust definition of healthcare
markets. Health Econ. 1998;7:167–170.
Farrell MG. ERISA preemption and regulation of managed medical care: the
case for managed federalism. Am J Law Med. 1997;23:251–289.
Feldman R, Given RS. HMO mergers and Medicare: the antitrust issues.
Health Econ. 1998;7:171–174.
Fifer WR. Compliance...or else! Minn Med. 1998;81:46–48.
Forgione DA. Corporate compliance plans in medical care organizations: a top-
down perspective. J Health Care Finance. 1998;24:87–92.
Frech HE III, Danger KL. Exclusive contracts between hospitals and physicians:
the antitrust issues. Health Econ. 1998;7:175–178.
Glaser D. 500 FBI agents. Iowa Med. 1996;86:110–112.
Glaser D. What to do if an investigator is at your office door.
Iowa Med. 1996;86:113–114.
Glaser DM. Medical care audits and investigations: act now to avoid trouble
later. Minn Med. 1996;79:43–46.
Greaney TL. Night landings on an aircraft carrier: hospital mergers and antitrust
law. Am J Law Med. 1997;23:191– 220.
Hebert DE, Ogaitis JM. Revised antitrust policy statements on healthcare.
AANA J. 1996;64:512–514.
Hirshfeld EB. Provider sponsored organizations and provider service
networks—rationale and regulation. Am J Law Med. 1996;22:263–300.
Hoffman DR. The federal effort to eliminate fraud and ensure quality care.
Adv Wound Care. 1997;10:36–38.
Iglehart JK. Pursuing medical care fraud and abuse.
Health Aff (Millwood). 1998;17:6.
Jost TS, Davies S. The fraud and abuse statute: rationalizing or rationalization?
Health Aff (Millwood). 1996;15:129–131.
Kleinke JD. Deconstructing the Columbia/HCA investigation.
Kurlander SS, Scherb E. Liability under the False Claims Act for inadequate care
of nursing facility residents. Adv Wound Care. 1997;10:47–49.
Kuttner R. Physician-operated networks and the new antitrust guidelines.
Engl J Med. 1997;336:386–391.
Lawton SE, Leibenluft RF, Loeb LE. Antitrust implications of physicians’
responses to managed care. Clin Infect Dis. 1995;20:1354–1360.
Liggett N. New law adds significant penalties for the waiver of copayments.
Tenn Med. 1997;90:354–355.
Luce GM, Graham JJ. Responding to a medical care fraud investigation: a
practice guide. Va Med Q. 1996;123:9–13.
Lundquist JW, Glaser DM. Fraud investigations: the heat is on.
Minn Med. 1998;81:49–51.
Mason C. Who carries the risk? Networks, antitrust, and carve- outs.
Acad Radiol. 1996;3:S150–S153.
McCampbell RG. Fraud and abuse provisions in the Health Insurance Portability
and Accountability Act: a guide to the new act for physicians.
J Okla State Med
McMenamin JP, Scoggins GA. Developing a compliance program to identify and
prevent inaccurate or improper Medicare billing practices.
Va Med Q. 1998;125:12–14.
Meyer A. The Health Insurance Portability and Accountability Act.
Tenn Med. 1997;90:86–89.
Miale PA. Wake-up call: can you protect yourself and your nuclear medicine
practice from fraud and abuse? J Nucl Med. 1998;39:21N–22N.
Minarik PA. Opposition to antitrust legislation: support for Medicaid and
Medicare reimbursement. Clin Nurse Spec. 1997;11:139–140.
Murphy LS. How much should physicians worry about antitrust?
Del Med J. 1997;69:305–309.
Nordenberg T. Selling drug samples lands doctor in prison.
FDA Consum. 1998;32:39.
Ortolon K. Medicare rerun: congress tinkers with but does not fix Medicare
solvency. Tex Med. 1997;93:28–32.
Parmley WW. Public enemy number 2: academic medicine under the Federal
spotlight. J Am Coll Cardiol. 1997;29:11– 17.
Phillips JR. Qui tam litigation: a new forum for prosecuting false claims against
the government. J Leg Med. 1993;14:267–277.
Polston MD. Reporting fraud. Am J Nurs. 1998;98:78.
Pristave RJ, Riley JB Jr. OIG on the warpath, II: when the OIG knocks on your
door. Nephrol News Issues. 1996;10:45–46.
Russell LS. Fraud, abuse, and IDSs.
J Law Med Ethics. 1996;24:162–166.
Sage WM. Judge Posner’s RFP: antitrust law and managed care.
Shepherd SR. The rewards of exposing fraud against the government.
J Pract Nurs. 1997;47:4–7.
Smith JJ, Gay SB. Reducing the number of radiology residents: antitrust and
action by the Accreditation Council for Graduate Medical Education.
Acad Radiol. 1996;3:766–769.
Spear SL. On the importance of being honest.
Plast Reconstr Surg. 1998;102:899.
Stahl DA. Consolidated billing and compliance program— Part 1.
Nurs Manage. 1998;29:16–18.
Stahl DA. Consolidated billing and compliance program— Part 2.
Nurs Manage. 1998;29:12–15.
Ward RD. Medicare fraud and abuse.
Mich Med. 1998;98:24– 31.